Phase
Condition
Lung Disease
Pleural Effusion
Treatment
N/AClinical Study ID
Ages 1-16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients under the age of 17
pleural fluid depth of at least 15mm, confirmed by ultrasound
at least one of the following severity criteria :
fever continuing 48h after starting correct antibiotherapy
respiratory distress
mediastinal displacement on the chest X-ray
Exclusion
Exclusion Criteria:
previous drainage by either Video-Assisted Thoracoscopic or pleural drainage bypercutaneous drain associated with urokinase- congenital pulmonary disorders with lungfunction impairment
congenital pulmonary disorders with lung function impairment
chronic pulmonary disease associated with lung function impairment
hemodynamic instability
congenital immunodeficiency disease
secondary immune deficiency induced
hemostasis disorder (contraindication of thrombolytic therapy)
pregnancy or breastfeeding patient
Study Design
Connect with a study center
Queen Fabiola University Children Hospital
Brussels, 1020
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.